Published in J Immunol on February 04, 2011
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol (2014) 1.15
Arginine and citrulline and the immune response in sepsis. Nutrients (2015) 0.93
At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol (2014) 0.91
Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids (2011) 0.90
Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. PLoS One (2011) 0.89
Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori. J Immunol (2014) 0.87
Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clin Transl Gastroenterol (2014) 0.87
Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis. Mucosal Immunol (2014) 0.86
Immune evasion strategies used by Helicobacter pylori. World J Gastroenterol (2014) 0.85
Gastric Helicobacter pylori Infection Affects Local and Distant Microbial Populations and Host Responses. Cell Rep (2016) 0.85
Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens. Biofactors (2013) 0.82
Dual role of arginine metabolism in establishing pathogenesis. Curr Opin Microbiol (2015) 0.82
The Immune Battle against Helicobacter pylori Infection: NO Offense. Trends Microbiol (2016) 0.82
Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response. Am J Physiol Gastrointest Liver Physiol (2013) 0.81
Suppression of cell division-associated genes by Helicobacter pylori attenuates proliferation of RAW264.7 monocytic macrophage cells. Sci Rep (2015) 0.81
EGFR regulates macrophage activation and function in bacterial infection. J Clin Invest (2016) 0.81
Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis. Gut Microbes (2016) 0.78
Editorial: Orchestration of macrophage polarization by polyamines. J Leukoc Biol (2012) 0.77
Arginase 2 deletion leads to enhanced M1 macrophage activation and upregulated polyamine metabolism in response to Helicobacter pylori infection. Amino Acids (2016) 0.77
Helicobacter pylori: Genomic Insight into the Host-Pathogen Interaction. Int J Genomics (2015) 0.77
Oxidative and nitrosative stress defences of Helicobacter and Campylobacter species that counteract mammalian immunity. FEMS Microbiol Rev (2016) 0.76
Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise. Free Radic Biol Med (2016) 0.76
Ornithine decarboxylase regulates M1 macrophage activation and mucosal inflammation via histone modifications. Proc Natl Acad Sci U S A (2017) 0.75
Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease. Front Immunol (2017) 0.75
Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases. Curr Top Microbiol Immunol (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer (2002) 10.19
Nitric oxide and the immune response. Nat Immunol (2001) 10.00
Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol (2005) 9.27
Arginine metabolism: nitric oxide and beyond. Biochem J (1998) 6.44
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res (2004) 4.74
H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut (2004) 4.66
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol (2008) 4.31
Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog (2009) 4.12
Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci U S A (1991) 4.01
Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol (1998) 3.98
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest (2008) 3.17
Macrophage plasticity in experimental atherosclerosis. PLoS One (2010) 2.75
CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology (2006) 2.39
Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology (2009) 2.22
Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst (1976) 2.14
Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst (1976) 2.09
The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol (2001) 2.08
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology (2007) 1.98
Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun (1995) 1.89
Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology (2007) 1.88
Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide (1997) 1.85
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A (2009) 1.81
Protective role of arginase in a mouse model of colitis. J Immunol (2004) 1.74
Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res (2004) 1.74
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter (2005) 1.70
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog (2006) 1.68
Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol Cell Biol (2001) 1.63
Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem (2004) 1.62
Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology (2008) 1.60
Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr (2007) 1.58
Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem (2004) 1.56
Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol (2002) 1.56
L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun (2007) 1.54
Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol (2007) 1.49
Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc Natl Acad Sci U S A (2005) 1.47
An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J Immunol (2007) 1.35
Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology (1996) 1.33
Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide Production. Gastroenterology (2010) 1.26
Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J Immunol (2010) 1.25
Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect Immun (2003) 1.19
Arginase I induction during Leishmania major infection mediates the development of disease. Infect Immun (2005) 1.15
The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc Natl Acad Sci U S A (2002) 1.13
Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophages. J Biol Chem (2010) 1.08
Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect. J Immunol (2004) 1.07
Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice. Infect Immun (2001) 1.03
Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect Immun (2008) 1.01
Low multiplicity of infection of Helicobacter pylori suppresses apoptosis of B lymphocytes. Cancer Res (2006) 0.98
Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut (2004) 0.96
Gastric cancer in Colombia. II. Case-control epidemiologic study of precursor lesions. J Natl Cancer Inst (1976) 0.94
In vivo and in vitro activation of caspase-8 and -3 associated with Helicobacter pylori infection. Microbes Infect (2002) 0.84
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest (2011) 2.16
Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut (2011) 2.08
Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol (2010) 1.84
Narcotic use in patients with Crohn's disease. Am J Gastroenterol (2005) 1.83
Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res (2004) 1.74
Protective role of arginase in a mouse model of colitis. J Immunol (2004) 1.74
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
The gastric precancerous cascade. J Dig Dis (2012) 1.70
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.69
Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis (2003) 1.68
Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J Biol Chem (2004) 1.62
HER2 as a therapeutic target in the gastric cancer: is it sufficient? Indian J Gastroenterol (2012) 1.58
Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res (2009) 1.57
Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem (2004) 1.56
Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol (2002) 1.56
L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun (2007) 1.54
Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol (2007) 1.49
Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A (2014) 1.48
Helicobacter pylori infection: pathogenesis. Curr Opin Gastroenterol (2003) 1.45
Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest (2012) 1.45
Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology (2011) 1.41
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res (2009) 1.40
A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. Cancer Res (2008) 1.36
Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol (2002) 1.31
The future of gastric cancer prevention. Gastric Cancer (2004) 1.30
Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology (2009) 1.28
Differential expression of stx2 variants in Shiga toxin-producing Escherichia coli belonging to seropathotypes A and C. Microbiology (2008) 1.26
Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide Production. Gastroenterology (2010) 1.26
Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J Immunol (2010) 1.25
Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J Biol Chem (2005) 1.22
Arginases in parasitic diseases. Trends Parasitol (2003) 1.21
Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer (2010) 1.18
A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res (2008) 1.15
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother (2007) 1.15
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest (2011) 1.15
The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. J Biol Chem (2010) 1.14
Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm Res (2008) 1.14
Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res (2012) 1.13
Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun (2008) 1.13
STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis (2011) 1.13
Helicobacter pylori Infection and Gastric Adenocarcinoma. US Gastroenterol Hepatol Rev (2011) 1.12
Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Am J Physiol Gastrointest Liver Physiol (2011) 1.12
Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-kappaB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. J Immunol (2007) 1.12
Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PLoS One (2012) 1.12
Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res (2008) 1.12
Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J (2010) 1.11
L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One (2012) 1.08
Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophages. J Biol Chem (2010) 1.08